Aikaterini Lalatsa-rekin lankidetzan egindako argitalpenak (3)

2019

  1. Tuning the transdermal delivery of hydroquinone upon formulation with novel permeation enhancers

    Pharmaceutics, Vol. 11, Núm. 4

2017

  1. Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections

    Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1095-1106

2015

  1. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles

    Molecular Pharmaceutics, Vol. 12, Núm. 2, pp. 420-431